Assessing the Effects of Educational Training Aimed to Improve Pain-reporting Reliability in Children After Surgery
12 mars 2020 mis à jour par: University of Haifa
Treating pain, just as treating other medical conditions, depends on accurate assessment of patient's condition. When assessing pain, as other subjective symptoms, the challenge is twofold because the assessment is dependent on patient's understanding and use of the scale, all the more so in children
So far, attempts to improve pain assessments have been focused on the development and refining pain scales. No emphasis has been placed on improving patient's ability to report their pain. Our purpose is to evaluate a training program designed to improve the quality of children's post-surgical pain intensity reports.
After receiving Helsinki approval, eligible children and their parents will signed informed-consent. After surgery, the children, their parents, and the department nurses will assess children's pain intensity. Immediately after the nurse assessment, parents will assess their child's pain (blindly and independently) and the children will report their pain on four different pain scales.
Children aged 8-17, hospitalized in Rambam medical-center for elective surgery will be invited to participate. Children in the experimental group will be exposed to a training program, developed for this study, aimed to teach and train how to report pain. The control group will receive the standard pre-surgical instructions.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Réel)
98
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Haifa, Israël, 3498838
- University of Haifa, The Clinical Pain Innovation Lab
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
8 ans à 17 ans (Enfant)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- children at age 8-17 years;
- absence of psychiatry, cognitive, and/or neurological disorders;
- understand the purpose and the instructions of the study, agree to participate and parent signed inform consent.
Exclusion Criteria:
1. children suffering from Post traumatic stress disorder.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Interventional arm
The intervention, which was aimed to educate children on how to use pain scales and provide reliable pain assessments was based on a two short animation clips, lasting approximately 5 min each, and a short (5 min) guided interaction between the study nurse and the participants, in between the two clips.
|
The first animation clip focuses on the importance of pain assessment introduce three pain scales (categorical, NPS and faces) followed by explanations on their properties and on the appropriate way to use them.The second movie was aimed to provide an opportunity to implement the new knowledge in case studies
|
|
Autre: Control
Children underwent the routine pre-operative preparations, which included a section on pain assessment.
|
Routine preoperative preparations, which included a section on pain assessment instructions.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Quality of pain intensity scores based on the concordance between pain reports on different scales.
Délai: Pain intensity rating before analgesic consumption.
|
The average difference between scores reported on the different scales was calculated as follows: The difference between to pain scores reported on each possible pairs of two scales was calculated in absolute values.
The average difference of the 6 pairs was calculated.
The 5-point CAT was transformed into a 0-10 scale by multiplying its values by 2.5.
|
Pain intensity rating before analgesic consumption.
|
|
Quality of pain intensity scores based on the concordance between pain reports on different scales.
Délai: Pain intensity rating one hour after analgesic consumption.
|
The average difference between scores reported on the different scales was calculated as follows: The difference between to pain scores reported on each possible pairs of two scales was calculated in absolute values.
The average difference of the 6 pairs was calculated.
The 5-point CAT was transformed into a 0-10 scale by multiplying its values by 2.5.
|
Pain intensity rating one hour after analgesic consumption.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
The difference between children assessment vs. nurses assessment.
Délai: NPS ratings before and one hour after analgesic consumption
|
The difference between children pain assessment vs. nurses assessment on a 0-10 numerical pain scale (NPS), in which 0 indicates "no pain" and 10 "the worst pain imaginable."
|
NPS ratings before and one hour after analgesic consumption
|
|
The average difference between children assessment vs. parents.
Délai: NPS ratings before and one hour after analgesic consumption
|
The difference between children pain assessment vs. parents assessment on a 0-10 numerical pain scale (NPS), in which 0 indicates "no pain" and 10 "the worst pain imaginable."
|
NPS ratings before and one hour after analgesic consumption
|
|
The average decrease in pain following analgesia: NPS
Délai: NPS ratings before and one hour after analgesic consumption
|
The average decrease in pain following analgesic consumption (Delta NPS) based on a 0-10 numerical pain scale (NPS), in which 0 indicates "no pain" and 10 "the worst pain imaginable."
|
NPS ratings before and one hour after analgesic consumption
|
|
Quality of pain intensity scores based on the concordance between pain reports on different scales.
Délai: Pain intensity ratings before analgesic consumption.
|
The within-subjects standard deviation (SD) between the 4 pain scores (provided at the same time of assessment).
To assure that variability will be appropriately reflected by this measure, subjects who reported only "0" or only "10" in all 4 scales were excluded from this analysis due to potential bias of the within-subjects SD due to floor or ceiling effects.
|
Pain intensity ratings before analgesic consumption.
|
|
Quality of pain intensity scores based on the concordance between pain reports on different scales.
Délai: Pain intensity ratings one hour after analgesic consumption.
|
The within-subjects standard deviation (SD) between the 4 pain scores (provided at the same time of assessment).
To assure that variability will be appropriately reflected by this measure, subjects who reported only "0" or only "10" in all 4 scales were excluded from this analysis due to potential bias of the within-subjects SD due to floor or ceiling effects.
|
Pain intensity ratings one hour after analgesic consumption.
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
20 juin 2019
Achèvement primaire (Réel)
20 novembre 2019
Achèvement de l'étude (Réel)
21 novembre 2019
Dates d'inscription aux études
Première soumission
8 mars 2020
Première soumission répondant aux critères de contrôle qualité
12 mars 2020
Première publication (Réel)
13 mars 2020
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
13 mars 2020
Dernière mise à jour soumise répondant aux critères de contrôle qualité
12 mars 2020
Dernière vérification
1 mars 2020
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 0091-19-RMB
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Non
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
produit fabriqué et exporté des États-Unis.
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .